This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through February 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
medical-devices: Archive
Here's Why You Should Retain INSP Stock in Your Portfolio for Now
by Zacks Equity Research
INSP navigates a product shift as Inspire V gains traction, reimbursement improves, and management balances growth with near-term pressures.
BSXNegative Net Change IDXXPositive Net Change STENegative Net Change INSPNegative Net Change
medical medical-devices
Here's Why You Should Retain Integer Holdings Stock in Your Portfolio
by Zacks Equity Research
ITGR leans on R&D and MedTech scale after a solid Q3 2025, but slower product adoption and supplier reliance cloud the near-term outlook.
CAHPositive Net Change COOPositive Net Change VCYTNegative Net Change ITGRPositive Net Change
medical medical-devices
BD and Ypsomed Expand Partnership to Target Growing Biologics Market
by Zacks Equity Research
BDX expands its Ypsomed partnership with a 5.5 mL Neopak XtraFlow syringe, targeting rising demand for large-volume subcutaneous self-injection.
BDXPositive Net Change CAHPositive Net Change COOPositive Net Change WSTNegative Net Change
medical medical-devices
Citizens Financial Services (CZFS) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
CZFSPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
4 Medical Supply Stocks Poised to Gain in a Prospering Industry
by Indrajit Bandyopadhyay
Here, we discuss four stocks from the Dental Supplies industry that are likely to generate wealth for investors amid tariff uncertainty. These are MCK, CAH, WST and ALGN.
MCKPositive Net Change ALGNPositive Net Change CAHPositive Net Change WSTNegative Net Change
medical medical-devices
Hologic Q1 Earnings Preview: How Should You Play the Stock Now?
by Moumi Mondal
HOLX heads into Q1 earnings with rising EPS and revenue estimates, strong segment momentum and a pending buyout limiting near-term upside.
ABTPositive Net Change HOLXPositive Net Change QGENPositive Net Change
earnings-preview medical medical-devices
BD Gets FDA 510(k) Approval for EnCor EnCompass Breast Biopsy System
by Zacks Equity Research
BDX wins FDA 510(k) clearance for the EnCor EnCompass breast biopsy system, set for an early 2026 launch to boost flexibility and patient care.
BDXPositive Net Change CAHPositive Net Change COOPositive Net Change VCYTNegative Net Change
medical medical-devices
CAPR Updates FDA on Deramiocel BLA, Plans HOPE-3 CSR Filing in February
by Zacks Equity Research
CAPR said the FDA wants the full HOPE-3 study report for Deramiocel and confirmed no new clinical trials are needed.
BSXNegative Net Change IDXXPositive Net Change STENegative Net Change CAPRNegative Net Change
medical medical-devices
3 Medical Info Systems Stocks to Gain From Digitization Despite Industry Woes
by Urmimala Biswas
Medical Info Systems rides AI and telehealth tailwinds, lifting DOCS, TXG and OMCL, but cyber risks and industry underperformance keep optimism in check.
DOCSPositive Net Change OMCLPositive Net Change TXGNegative Net Change
artificial-intelligence earnings hospitals medical medical-devices
ISRG vs. MDT: Which MedTech Stock Is a Better Bet Now?
by Indrajit Bandyopadhyay
Intuitive Surgical's pure-play robotics focus, rising da Vinci 5 utilization and 85% recurring revenues tilt the risk-reward versus diversified Medtronic.
MDTNegative Net Change ISRGPositive Net Change
medical medical-devices